Sarecycline - Almirall S.A./Paratek Pharmaceuticals

Drug Profile

Sarecycline - Almirall S.A./Paratek Pharmaceuticals

Alternative Names: P 0005672; P 005672; Seysara; WC-3035

Latest Information Update: 05 Oct 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Paratek Pharmaceuticals
  • Developer Actavis; Almirall S.A.; Paratek Pharmaceuticals
  • Class Amides; Antiacnes; Antibacterials; Naphthacenes; Skin disorder therapies; Small molecules; Tetracyclines
  • Mechanism of Action Ribosomal protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Acne vulgaris

Highest Development Phases

  • Registered Acne vulgaris
  • No development reported Rosacea

Most Recent Events

  • 05 Oct 2018 Sarecycline - Almirall S.A./Paratek Pharmaceuticals is available for licensing in (excluding USA) as of 05 Oct 2018.
  • 01 Oct 2018 Registered for Acne vulgaris (In adolescents, In children, In adults) in USA (PO) - First global approval
  • 03 Aug 2018 Almirall S.A. acquires sarecycline from Allergan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top